NPI registry status
Active
2026 NPPES data Podiatrist NPI 1124081575 DPM
Verify on CMS → Jeffery Lamour, DPM
Podiatrist in Austin, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,602 in Podiatrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
318
Medicare Part D claims · 179 beneficiaries · Podiatrist avg: 320
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 84 pts below national avg 83.5 · Penalty band
Industry payments
$160.27
8 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Jeffery Lamour, DPM reported a CMS MIPS final score of 0/100 - below the 83.5 national average - and filed 318 Medicare Part D claims in 2024.
- 0/100
- MIPS score · -83 vs avg
- 318
- Part D claims, 2024
- 86%
- generic prescribing
- $160.27
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jeffery Lamour, DPM
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1124081575), first enumerated 04/07/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 318 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 0/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Industry payment transparency
$160.27 in reported industry payments (8 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Jeffery Lamour, DPM's individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1124081575 · Podiatrist
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1124081575
- ENUM-LEGACY 2006
- TAX-MID 11K Podiatrist
- MIPS-LOW 0/100
- RX-LIGHT 318
- BOOK-LIGHT 608 in Texas
- PHOTO-FINISH Keith Arbuckle, D.P.M. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Lamour · this pr… 0
Lamour · this provider
0 MIPS pts
- Robert Buckenber… 0
Robert Buckenberger, DPM
0 MIPS pts
- Keith Arbuckle, … 0
Keith Arbuckle, D.P.M.
0 MIPS pts
- David Bates, DPM… 0
David Bates, DPM
0 MIPS pts
- James Bowman, DP… 0
James Bowman, DPM
0 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Jeffery Lamour, DPM's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
0 ≥ 0th percentile 0% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jeffery Lamour, DPM sits
This provider among podiatrist peers
Across the 2,362 podiatrist providers who report both Medicare Part D prescribing and a MIPS quality score, Jeffery Lamour, DPM writes more Part D claims than 67% of them and scores higher on MIPS quality than 0% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one podiatrist peer from a representative sample of 60; the gold marker is Jeffery Lamour, DPM. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Jeffery Lamour, DPM?
Below national averagePrimary specialty
Podiatrist
Medicare Part D claims
318 1% vs specialty avg
MIPS final score
0/100 83.5 pts vs avg
Specialty distribution in Texas
How Podiatrist compares to other specialties among Texas providers
Medicare quality performance, MIPS
Jeffery Lamour, DPM's 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 0/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1124081575 |
|---|---|
| Specialty | Podiatrist |
| Credentials | DPM |
| Gender | Male |
| NPI Issued | 04/07/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
0
Final Score
Measured-score avg: 83.5
0
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jeffery Lamour, DPM. Source: openpaymentsdata.cms.gov.
Total received
$160
Largest payer
Abbott Laboratories
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Jeffery Lamour, DPM. To verify Jeffery Lamour, DPM's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Jeffery Lamour, DPM - brand share 14.0%
Podiatrist average
14% brand-name claims vs 86% generic, on 318 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
318
Total Claims
$54K
Total Drug Cost
179
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 350.9
- Total Day Supply
- 8,450
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $45K
- Generic Drug Cost
- $9K
- Antibiotic Claims
- 41
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.20
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 11, 65-74: 96, 75-84: 59, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jeffery Lamour, DPM prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ciclopirox
Ciclopirox
89 claims
- Meloxicam
Meloxicam
48 claims
- Jublia
Jublia
40 claims
- Cefuroxime 26
Cefuroxime
26 claims
- Tavaborole 26
Tavaborole
26 claims
- Neomycin-Polymyxin… 17
Neomycin-Polymyxin-Dexameth
17 claims
- Celecoxib 15
Celecoxib
15 claims
| Drug | Claims |
|---|---|
| Ciclopirox Ciclopirox Olamine | 89 |
| Meloxicam | 48 |
| Jublia Efinaconazole | 40 |
| Cefuroxime Cefuroxime Axetil | 26 |
| Tavaborole | 26 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 17 |
| Celecoxib | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How Jeffery Lamour, DPM fits within the Podiatrist landscape nationally.
10,602
Podiatrist Providers in US
54
States with Podiatrist
320
Avg Claims per Provider
Jeffery Lamour, DPM's 318 claims are below the specialty average of 320.
Nationwide Podiatrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Lamour, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (0 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Podiatrist Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Lamour.
One of 608 Podiatrist providers enrolled in Texas, 5 are shown here.
Dr. Brian Abbey
DPM
College Station, TX
Dr. Murad Abdel-Qader
DPM
San Antonio, TX
Dr. Hannah Abigail
DPM
Sherman, TX
Dr. Vivian Abrams
D.P.M.
McKinney, TX
Dr. Rita Acebo
DPM
Pasadena, TX
Compare Podiatrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jeffery Lamour, DPM's specialty? ▼
Jeffery Lamour, DPM specializes in Podiatrist and practices in Austin, Texas. Credentials: DPM.
How much does Jeffery Lamour, DPM prescribe under Medicare Part D? ▼
In 2024, Jeffery Lamour, DPM wrote 318 Medicare Part D claims totaling $54K in drug costs for 179 beneficiaries.
What is Jeffery Lamour, DPM's Medicare quality score? ▼
Jeffery Lamour, DPM has a CMS MIPS Final Score of 0/100 (Quality: 0). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jeffery Lamour, DPM located? ▼
Jeffery Lamour, DPM is located at 8015 SHOAL CREEK BLVD, Austin, TX, 78757. Phone: (512) 451-3668.
What is Jeffery Lamour, DPM's NPI number? ▼
Jeffery Lamour, DPM's National Provider Identifier (NPI) is 1124081575, issued on 04/07/2006.
Does Jeffery Lamour, DPM prescribe more brand-name or generic drugs? ▼
Jeffery Lamour, DPM's prescribing is 14% brand-name and 86% generic drugs by claim count, with $45K in brand drug costs.
How many Podiatrist providers are there in the US? ▼
There are 10,602 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 320 Medicare Part D claims per year.
What drugs does Jeffery Lamour, DPM prescribe most often? ▼
Based on 2024 Medicare Part D data, Jeffery Lamour, DPM's most frequently prescribed drugs include Ciclopirox, Meloxicam, Jublia. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jeffery Lamour, DPM accept Medicare? ▼
Jeffery Lamour, DPM appears in CMS Medicare data with 318 Part D claims and 179 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jeffery Lamour, DPM's credentials? ▼
Jeffery Lamour, DPM's NPI is 1124081575 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.